Senate Panel To CMS: Hike MA Marketing Oversight Or Congress Might Act

By Michelle M. Stein / November 3, 2022 at 5:00 AM

The Senate Finance Committee put CMS on notice Thursday (Nov. 3) that the agency needs to step up its oversight of Medicare Advantage marketing practices or Congress might step in.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.